Justification for initiating patiromer when restricted by prior authorization and clinical guidance in a US health care system

BACKGROUND: In the Veterans Health Administration, patiromer is a formulary medication restricted by prior authorization and criteria-for-use (CFU). Historically, patiromer approval was restricted by step therapy, requiring prescribers to trial sodium polystyrene sulfonate (SPS). OBJECTIVE: To descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Shardool, Qualls, Joshua, Pinnell, Derek, Rathod, Anitha, Chen, Wei, Sauer, Brian C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372981/
https://www.ncbi.nlm.nih.gov/pubmed/36427342
http://dx.doi.org/10.18553/jmcp.2022.28.12.1410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372981/
https://www.ncbi.nlm.nih.gov/pubmed/36427342
http://dx.doi.org/10.18553/jmcp.2022.28.12.1410

Ejemplares similares